MRI Interventions Adds ClearPoint® Neuro Navigation to Another Top-Ten Ranked Children’s Hospital
IRVINE, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that Children’s National Hospital in Washington DC, ranked number nine in the country for pediatric neurosurgery by U.S. News and World Report, performed its first case utilizing the ClearPoint® Neuro Navigation System. The ClearPoint System is now being utilized in seven of the top ten nationally ranked Children’s Hospitals for Neurosurgery and Neurology, as well as several other leading hospitals specializing in pediatric care.
“We are pleased to see this prestigious institution adopt our technology to enhance the care they provide to their pediatric neurosurgery patients,” said Frank Grillo, President and CEO of MRI Interventions, Inc. “Our total installed base now exceeds 50 hospitals, and children’s hospitals have been early adopters. The pediatric neurosurgeons in these hospitals understand the value of being able to see the brain anatomy in real-time MRI during the procedure, as these patients are still growing and their brain is still developing. With ClearPoint, the surgeon can be sure of careful and accurate placement of devices as needed.”
Real time MRI imaging provides the surgeon with current views of the patient’s brain anatomy at the time of surgical planning, device alignment, and navigation of selected device to target, resulting in improved accuracy so critical in the pediatric population. Only ClearPoint Neuro Navigation enables laser ablation procedures to be performed entirely in the MRI suite, eliminating the need to transport the patient mid-procedure from the operating room to the MRI suite. The ClearPoint System enables a minimally invasive approach which allows surgeons to plan, target, and adjust trajectories under real time MRI-guided visualization for placement of electrodes, catheters and biopsy needles.
About MRI Interventions, Inc.
Building on the imaging power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Statements herein concerning MRI Interventions, Inc. (the “Company”) plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: future revenues from sales of the Company’s ClearPoint Neuro Navigation System products; and the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint Neuro Navigation System products. More detailed information on these and additional factors that could affect the Company’s actual results are described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, and the Company’s Quarterly Report on Form 10-Q, both of which have been filed with the Securities and Exchange Commission.
Contact: Wendelin Maners, VP, Sales and Marketing MRI Interventions, Inc. 949-900-6833 For Investors: Matt Kreps, Darrow Associates Investor Relations (512) 696-6401 firstname.lastname@example.org